Lam Research (NASDAQ:LRCX) Stock Price Down 2.3% – Here’s What Happened

Lam Research Corporation (NASDAQ:LRCX) fell 2.3% during trading on Wednesday . The company traded as low as $227.36 and last traded at $233.45. 8,271,338 shares changed hands during trading, a decline of 31% from the average session volume of 12,039,925 shares. The stock had previously closed at $238.84.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Jim Cramer publicly called Lam “a winner” on Mad Money, tying its strength to recent semiconductor wins (Micron mention). Short-term: increased retail visibility and sentiment can drive flows and volatility. Jim Cramer on Lam Research: “You’ve Got a Winner in Lam Research”
• Positive Sentiment: Reports of “outlier inflows” into LRCX-related signals point to continued sizeable capital inflows that have historically lifted the stock. Impact: institutional/quant flows can prop up price momentum even amid broader market weakness. Outlier Inflows Push Lam Research Shares Higher
• Positive Sentiment: Analyses and sector roundups note Lam’s strong Q4 execution and relative outperformance among semiconductor equipment peers. For investors: earnings strength supports fundamentals and near-term guidance credibility. Why the Market Dipped But Lam Research (LRCX) Gained Today
• Positive Sentiment: Institutional commentary (Insidermonkey referencing Renaissance’s letter) highlights Lam’s positioning to benefit from growing chip complexity — a structural demand tailwind for etch/deposition equipment. Implication: durable end-market growth supports higher multi-year revenue and margin potential. Lam Research Corporation (LRCX) is Positioned to Benefit from Growing Chip Complexity
• Neutral Sentiment: Feature pieces (Seeking Alpha) argue for strong growth ahead but note the stock looks expensive — a classic growth-at-a-price tradeoff. Effect: bullish thesis intact but limits upside unless earnings multiple expands or growth accelerates further. Lam Research: Strong Growth Ahead For This Expensive Stock
• Neutral Sentiment: Valuation-focused write-ups examine multi-year shareholder returns and current multiples; investors should weigh premium P/E against continued cyclical/structural upside. This is a reminder valuation is a key risk/reward driver for LRCX. Assessing Lam Research (LRCX) Valuation After Strong Multi Year Shareholder Returns
• Neutral Sentiment: Short-interest reports in the feed show anomalous/zero values and apparent reporting errors; no reliable signal of a squeeze or mounting bearish bets from these data points. Investors should consult official exchange short-interest releases before acting. (No external link — data entries flagged in feed.)

Analyst Ratings Changes

Several equities analysts have recently weighed in on LRCX shares. Sanford C. Bernstein lifted their price objective on Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Monday, February 9th. Mizuho set a $265.00 target price on Lam Research in a research note on Wednesday, January 28th. TD Cowen increased their price objective on shares of Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Argus increased their target price on Lam Research from $175.00 to $280.00 in a report on Tuesday, February 3rd. Finally, Needham & Company LLC raised their price target on shares of Lam Research from $250.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $245.35.

Lam Research Trading Down 2.3%

The firm has a market capitalization of $291.53 billion, a price-to-earnings ratio of 47.84, a price-to-earnings-growth ratio of 2.51 and a beta of 1.77. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The firm’s 50 day moving average is $227.67 and its 200 day moving average is $180.02.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s payout ratio is 21.31%.

Insider Activity

In other news, insider Ava Harter sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the sale, the insider directly owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This represents a 2.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 130,886 shares of company stock valued at $29,658,802 over the last three months. Insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in LRCX. PMV Capital Advisers LLC purchased a new stake in shares of Lam Research in the 4th quarter valued at approximately $25,000. Stance Capital LLC purchased a new position in Lam Research during the 3rd quarter worth approximately $26,000. Bayban acquired a new stake in Lam Research during the 4th quarter valued at $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research during the 2nd quarter valued at $27,000. Finally, Triumph Capital Management purchased a new stake in shares of Lam Research in the third quarter valued at $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.